Showing results (1681-1690 of 2,038) with videos related to

Sort By:
Pageof 204
The Lancet. Oncology|March 4, 2021
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysisLaila A Gharzai, Ralph Jiang, David Wallington, et al.
Cancer Discovery|April 6, 2013
Identification of targetable FGFR gene fusions in diverse cancersYi-Mi Wu, Fengyun Su, Shanker Kalyana-Sundaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2020
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 StudyWassim Abida, David Campbell, Akash Patnaik, et al.
European Urology|December 14, 2017
Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence PostprostatectomyDaniel E Spratt, Darlene L Y Dai, Robert B Den, et al.
The Journal of Urology|August 29, 2018
International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone TherapyAlejandro Berlin, Fabio Y Moraes, Noelia Sanmamed, et al.
Cancer Research|November 9, 2022
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate CancerJonathan Chou, Emily A Egusa, Sinan Wang, et al.
European Urology|June 26, 2025
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate DataSarah Burdett, David J Fisher, Jayne F Tierney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2018
Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical ProstatectomyR Jeffrey Karnes, Vidit Sharma, Voleak Choeurng, et al.
Research Square|November 11, 2020
Sex differences in viral entry protein expression and host transcript responses to SARS-CoV-2Mengying Sun, Rama Shankar, Meehyun Ko, et al.
Nature Cancer|June 4, 2021
A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistanceJuan M Arriaga, Sukanya Panja, Mohammed Alshalalfa, et al.
Pageof 204